CareDx Inc (NASDAQ: CDNA) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.62 versus a loss $-2.21 for the same period a year ago — a decline of -173%. For the […]
For its fourth fiscal quarter (ending December 31), Barrett Business Services Inc (NASDAQ: BBSI) has reported a -70% decline in E.P.S. from $2.20 a year ago to $0.65 in the current quarter. For the latest […]
For its fourth fiscal quarter (ending December 31), Avista Corp (NYSE: AVA) has reported a -22% decline in E.P.S. from $1.08 a year ago to $0.84 in the current quarter. E.P.S. were $2.29 for the […]
For its fourth fiscal quarter (ending December 31), Avanos Medical Inc (NYSE: AVNS) has reported a -3696% decline in E.P.S. from $0.24 a year ago to $-8.63 in the current quarter. E.P.S. were $-8.40 for […]
For its fourth fiscal quarter (ending December 31), Applied Optoelectronics Inc (NASDAQ: AAOI) has reported a 584% increase in E.P.S. from $-0.38 a year ago to $-2.60 in the current quarter. E.P.S. were $-4.50 for […]
Agilent Technologies Inc (NYSE: A) has reported earnings for its first fiscal quarter (ending January 31) of $1.12 versus $1.19 for the same period a year ago — a decline of -6%. For the latest […]
For its fourth fiscal quarter (ending December 31), Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has reported a 207% increase in E.P.S. from $0.28 a year ago to $0.86 in the current quarter. E.P.S. were $1.37 for […]
AMERISAFE Inc (NASDAQ: AMSF) has reported E.P.S. of $0.69 for its fourth fiscal quarter (ending December 31) versus $1.00 for the same period a year ago — a decline of -31%. For the latest four […]
On 2/26/25, United Therapeutics Corp (NASDAQ: UTHR) stock suffered a major decline of -10.8%, closing at $318.89. Moreover, this decline was accompanied by exceptionally high trading volume at 435% of normal. The stock has declined […]
For its fourth fiscal quarter (ending January 31), The TJX Companies Inc (NYSE: TJX) has reported a 1% increase in E.P.S. from $1.22 a year ago to $1.23 in the current quarter. E.P.S. were $4.26 […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research